Cargando…
Cognition among individuals along a spectrum of increased risk for Parkinson’s disease
INTRODUCTION: Several characteristics associated with increased risk for Parkinson’s disease (PD) have been identified, including specific genotypes and various non-motor symptoms. Characterizing non-motor features, such as cognitive abilities, among individuals considered at-risk for PD is essentia...
Autores principales: | Chahine, Lana M., Urbe, Liz, Caspell-Garcia, Chelsea, Aarsland, Dag, Alcalay, Roy, Barone, Paolo, Burn, David, Espay, Alberto J., Hamilton, Jamie L., Hawkins, Keith A., Lasch, Shirley, Leverenz, James B., Litvan, Irene, Richard, Irene, Siderowf, Andrew, Coffey, Christopher S., Simuni, Tanya, Weintraub, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6101368/ https://www.ncbi.nlm.nih.gov/pubmed/30125297 http://dx.doi.org/10.1371/journal.pone.0201964 |
Ejemplares similares
-
Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease
por: Weintraub, Daniel, et al.
Publicado: (2020) -
Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease
por: Caspell-Garcia, Chelsea, et al.
Publicado: (2017) -
Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease: the PPMI cohort
por: Simuni, Tanya, et al.
Publicado: (2018) -
Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort
por: Simuni, Tanya, et al.
Publicado: (2022) -
LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts
por: Merchant, Kalpana M., et al.
Publicado: (2023)